PDL BioPharma, Inc. Business Combination, Contingent Consideration, Liability, Current
PDL BioPharma, Inc. had Business Combination, Contingent Consideration, Liability, Current of $0 as of 2019-12-31, per its 8-K filed 2020-06-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2020-06-29
- 2019-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2019-09-30: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2019-06-30: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2019-03-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2019-12-31 | $0.00 8-K · filed 2020-06-29 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.07M 8-K · filed 2020-06-29 |
| 2018-09-30 | $1.07M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.14M 10-Q · filed 2018-08-09 |
| 2018-01-06 | $920.00K 10-Q · filed 2018-11-07 |
| 2018-01-05 | $920.00K 8-K · filed 2020-06-29 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-09 |